BioCentury
ARTICLE | Company News

cSens, Biovica deal

May 23, 2016 7:00 AM UTC

Biovica acquired fellow diagnostic company cSens in a “non-cash issue.” cSens’ PCR-based platform analyzes serum thymidine kinase enzyme activity to measure tumor and cancer progression. cSens did not...